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For over two decades, the World Organisation for Animal Health (OIE) has engaged in
combatting antimicrobial resistance (AMR) through a One Health approach. Monitoring
of antimicrobial use (AMU) is an important source of information that together with
surveillance of AMR can be used for the assessment and management of risks related
to AMR. In the framework of the Global Action Plan on AMR, the OIE has built a global
database on antimicrobial agents intended for use in animals, supported by the Tripartite
(World Health Organization (WHO), Food and Agriculture Organization of the United
Nations (FAO) and OIE) collaboration. The OIE launched its first annual data collection
in 2015 and published the Report in 2016. The second Report, published in 2017,
introduced a new methodology to report quantitative data in the context of relevant
animal populations, and included for the first time an annual analysis of antimicrobial
quantities adjusted for animal biomass on a global and regional level. A continuing annual
increase of countries participating in the data collection demonstrates the countries
engagement for the global development of monitoring and surveillance systems in line
with OIE international standards. Where countries are not yet able to contribute their
quantitative data, their reports also highlight the barriers that impede them in data
collection, analysis and/or reporting. The OIE Reports show annual global and regional
estimates of antimicrobial agents intended for use in animals adjusted for animal biomass,
as represented by the quantitative data reported by countries to the OIE. The OIE advises
caution in interpretation of estimates made in the first few years of reporting recognizing
some important limitations faced by countries as they develop their monitoring systems.
The OIE remains strongly committed to supporting its Members in developing robust and
transparent measurement and reporting mechanisms for AMU.
Keywords: antimicrobial resistance (AMR), antimicrobial use (AMU), report, methods/methodology, surveillance,
monitoring
INTRODUCTION
The World Organisation for Animal Health (OIE) has worked actively for more than two
decades on veterinary products, including antimicrobial agents, and developed a coherent strategy
for its activities in this area (1). Monitoring of antimicrobial use (AMU) is an important
source of information that, together with surveillance of AMR, can be used for the assessment
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and management of risks related to AMR. Toward
standardization of surveillance and monitoring data worldwide,
the OIE developed standards on “Monitoring of the quantities
and usage patterns of antimicrobial agents used in food
producing animals” [(2) Terrestrial Animal Health Code
Chapter 6.9.], “Monitoring of the quantities and usage patterns
of antimicrobial agents used in aquatic animals” [(3) Aquatic
Animal Health Code Chapter 6.3.] and on the “Harmonization
of national antimicrobial resistance surveillance and monitoring
programmes” [(2) Terrestrial Animal Health Code Chapter 6.8.],
and “Development and harmonization of national antimicrobial
resistance surveillance and monitoring programmes for aquatic
animals” [(3) Aquatic Animal Health Code Chapter 6.4] (3).
In the framework of the Global Action Plan on AMR, the OIE
has also built a global database on antimicrobial agents intended
for use in animals, supported by the Tripartite collaboration
(WHO, FAO, OIE).
TheOIE ad hocGroup onAntimicrobial Resistance developed
a template for harmonized AMU data collection, as well as
guidance for its completion that are available in the three official
OIE languages (i.e., English, French, and Spanish) (4).
The OIE launched its annual data collection on AMU in 2015,
and published the first Report in 2016 (5).
The second Report, published in 2017, introduced a new
methodology to report quantitative data in the context of relevant
animal populations and included for the first time an annual
analysis of antimicrobial quantities adjusted for animal biomass
on a global and regional level (6). The third report using the
same methodology was published in February 2019 (7). The OIE
animal biomass methodology was developed with the goal of best
representing animal biomass in all OIE Regions, with different
animal populations and production systems, and data collection
systems, using the data available at the international level.
The methodology for the animal biomass calculation was
developed with the support and validation of the OIE ad hoc
Group on Antimicrobial Resistance, and shared with Member
Countries in the report of the OIE Scientific Commission for
Animal Diseases meeting of September 2017.
The methodology for calculating animal biomass on a global
level, used by the OIE for analysis of reported data on
antimicrobial agents intended for use in animals, is detailed in
this article.
MATERIALS AND METHODS
OIE AMU Data Collection
Each year in October, the template and accompanying guidance
documents are sent to all 182 OIE Member Countries and 11
non-OIE Member Countries. The deadline for submission is
December, but responses may be accepted until mid-May of the
following year.
The template, to be completed by the respondents, is provided
in the form of an Excel file that includes four worksheets labeled
“Baseline Information,” “Reporting Option 1,” “Reporting Option
2,” and “Reporting Option 3.”
The “Baseline Information” sheet can be answered by any
country, and collects general information on topics including
the use of antimicrobials as growth promoters, and any barriers
to reporting quantitative data on antimicrobial agents used
in animals.
For countries able to provide quantitative data on
antimicrobial agents intended for use in animals, the Baseline
Information sheet also contains questions relevant to data
collection such as data sources, year and animal species covered
by the reported data.
Following completion of the Baseline Information, the
template either directs countries to submit the questionnaire if
no quantitative data are available, or to complete one of the
three “Reporting Options” if quantitative data are available. The
three reporting options represent increasing levels of detail of
quantitative data on antimicrobial classes used in animals, with
the possibility of separating amounts reported by type of use
(“veterinary medical use,” which includes use to treat, control,
or prevent disease; and “non-veterinary medical use,” which
includes use for growth promotion), animal groups (terrestrial
food-producing, aquatic food-producing, or companion) and
routes of administration.
Antimicrobial Agents Reported
For the harmonization of the submitted data, the OIE
established the List of antimicrobial classes to be reported
by the participant countries (Table 1). Data on antimicrobials
sold/imported/prescribed/used in the country in animals
are reported at the class/subclass level. All pharmaceutical
forms are included. The quantities for each antimicrobial
class can be reported either for veterinary medical use
(including prevention of clinical signs) or for growth
promotion purpose.
If there are confidentiality or proprietary reason that imped
a country to individually report the quantities for one or
more antimicrobial classes, such quantities should report as
“Aggregated class data,” an existing category in all three
Reporting Options proposed by the OIE. The country that uses
this category should list the names of the antimicrobial classes
that cannot be reported individually.
For each cycle of data collection, a specific year is targeted—
for example, data from 2015 for the third report published in
2019. However, countries with more recent quantitative data may
also report that data.
For each reported year, the country informs the OIE on
the period of time covered within the year, the data sources
(Table 2), coverage of the data (if is <100% the country explains
which quantitative data is inaccessible), animal groups covered
(terrestrial food-producing animals, aquatic food-producing
animals, and companion animals), food-producing species
covered, species considered companion animals covered by the
data and the link to the national report available on the web,
if any.
Calculation of Kilograms of Active Ingredients
For the purpose of reporting data on antimicrobial
quantities (amounts sold or imported for use in
animals expressed in kilograms (kg) of antimicrobial
agent, i.e., chemical compound as declared on the
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TABLE 1 | Classes of antimicrobial agents for reporting.
Antimicrobial
class
Guidance
Aminoglycosides Includes aminocyclitols (e.g., streptomycin,
dihydrostreptomycin, and spectinomycin) and all other
aminoglycosides (e.g., gentamicin, kanamycin,
neomycin, apramycin).
Amphenicols Includes florfenicol and thiamphenicol.
Arsenicals Includes nitarsone, roxarsone, and others.
Cephalosporins May be reported as,
• Cephalosporins (all generations) or
• In relevant category groupings:
◦ 1–2 generation cephalosporins and
◦ 3–4 generation cephalosporins
Fluoroquinolones Includes danofloxacin, difloxacin, enrofloxacin,
marbofloxacin, and other fluoroquinolones, but not other
quinolones (e.g., flumequine, oxolinic acid, nalidixic acid),
which are reported separately.
Glycopeptides Includes avoparcin and others.
Glycophospholipids Includes bambermycin (i.e., flavomycin).
Lincosamides Includes lincomycin, pirlimycin, and others.
Macrolides Includes substances with all macrolide structures, such
as erythromycin, spiramycin, tylosin, tylvalosin,
gamithromycin, tildipirosin, tulathromycin, and others.
Nitrofurans Includes furazolidone, nitrofurantoin, nitrofurazone, and
others.
Orthosomycins Includes avilamycin and others.
Other quinolones Includes flumequine, nalidixic acid, oxolinic acid, and
others.
Penicillins Includes all penicillins (e.g., natural penicillins,
aminopenicillins, and others), but excludes other beta
lactam antimicrobials like cephalosporins.
Pleuromutilins Includes tiamulin, valnemulin, and others.
Quinoxalines Includes carbadox, olaquindox, and others.
Streptogramins Includes virginiamycin, pristinamycin, and others.
Sulfonamides
(including
trimethoprim)
Includes all sulfonamides, as well as trimethoprim, and
similar compounds.
Tetracyclines Includes chlortetracycline, doxycycline, tetracycline, and
oxytetracycline.
Others All others not covered, including coumarin antimicrobials,
e.g., novobiocin, fusidic acid, kirromycins, phosphonic
acids like fosfomycin, rifamycins, thiostrepton.
product label, that is to be calculated from the available
information), animals are grouped into “all animal
species,” “companion animals,” “all food-producing
animals,” “terrestrial food-producing animals,” and “aquatic
food-producing animals.”
The amount of the antimicrobial agents intended for
use in animals in kilograms (kg) (the chemical compound
or active ingredient as declared on the product label, that
is to be calculated from the available information) should
be reported. Where data are available in the form of
number of packages of a given pharmaceutical preparation
sold/imported/prescribed/used; international units (IU) and;
percentage weight per volume (% w/v), mathematical conversion
TABLE 2 | Data Sources proposed by the OIE.
Sales data Wholesalers
Retailers
Marketing authorization holders
Registration authorities
Feed mills
Pharmacies
Farms shops/agricultural suppliers
Industry trade associations
Purchase Data Wholesalers
Retailers
Feed mills
Pharmacies
Agricultural cooperatives
Producer organizations
Import data Customs declarations—veterinary
medicinal product
Customs declarations—active ingredients
Veterinary data Sales
Prescriptions
Antimicrobial use data Farm records
Other data source(S) Other—free text field
are necessary in order to report the kilograms of active
ingredients to the OIE.
Ideally, the OIE is interested in the amount of active
ingredient (moiety), that is, the substance as listed in the
OIE List of antimicrobial agents of veterinary importance (8)
(e.g., benzylpenicillin), not the total weight of the actual
chemical compound (salt, ester, or other, for example: sodium or
potassium benzylpenicillin) contained in a veterinary medicinal
product or traded as bulk material. At this stage of the project,
the precision gained by the refined reporting of amounts of active
ingredient, achieved by mathematical conversion of amounts of
chemical compound as declared on the product label, is not
justified. Therefore, the OIE template accepts the amounts of
chemical compound as declared on the product label.
Since the second year of data collection, a question was
added to the template in order to understand the barriers
impeding countries from reporting amounts of antimicrobial
agents in animals. This information is useful for guiding
discussion on overcoming barriers during training Seminars
of National Focal Points for Veterinary Products (those who
most frequently complete the OIE Template) and increasing
availability of quantitative data in the future, and reflects
challenges in National Action Plan implementation that would
also be assessed during the Performance of the Veterinary
Services (PVS pathway) evaluation.
The barriers highlighted by responding countries are grouped
into four main categories (Lack of regulatory framework, Lack
of coordination/cooperation between national authorities and
with private sector, Lack of tools and human resources, and
Insufficient regulatory enforcement).
Frontiers in Veterinary Science | www.frontiersin.org 3 September 2019 | Volume 6 | Article 317
Góchez et al. OIE Antimicrobial Use Data: Methods
Validation of the Data and Calculations Performed at
the OIE Level on Antimicrobials Quantities
The OIE systematically reviews the reported information and
systematically comes back to responding countries to clarify
some issues, or to request missing data.
Whenever possible, the data reported by countries are checked
by the OIE against existing reference sources, using the previous
year’s reported data and/or national reports available online.
The indicator for this comparison is a calculated “percentage of
change” relative to the reference.
In the countries with high percentages of unexplained change
(> ±25%), the OIE inquires how the calculations to obtain kg
of antimicrobial agents sold/used were carried out. Through this
process, errors in the calculations can be identified and corrected.
When all the responses have been validated, the OIE proceeds
with analysis toward preparation of the report. The amounts of
antimicrobials sold/used are calculated by country, by region, by
animal groups, type of use, and pharmaceutical forms.
As all the countries do not provide the same level of details,
some calculations are done on only a part of the countries
providing quantitative data.
Through this process, the final result is a quantity of
antimicrobials sold/used expressed in kg/country/year. As many
countries are still in the process of developing their data
collection systems, these results are reported by the OIE on the
global and regional level at this stage.
OIE Calculation of the Animal Biomass
To compare quantitative data reported on antimicrobial agents
intended for use in animals between regions and over time, a scale
is necessary to evaluate these data in the context of the relevant
animal populations, which vary in size, and composition.
Therefore, the quantitative data reported on antimicrobial
agents intended for use in animals needs to be adjusted for the
relevant animal biomass according to the following calculation:
antimicrobial agents reported (mg)
animal biomass (kg)
Animal biomass is calculated as the total weight of the live
domestic animals in a given population present during a year in
a specific area, used as a proxy to represent those likely exposed
to the quantities of antimicrobial agents reported.
Animal biomass is currently employed as a denominator
in analysis of quantitative antimicrobial use data by other
national and regional antimicrobial use surveillance groups,
such as the European Surveillance of Veterinary Antimicrobial
Consumption (ESVAC)—(9), the Canadian Integrated Program
for Antimicrobial Resistance Surveillance (CIPARS)—(10), and
the Japanese Veterinary Antimicrobial Resistance Monitoring
System (JVARM, (11)). In 2017 the US FDA proposed a method
for estimating a Biomass denominator (12).
While several methodologies have been developed for the
calculation of animal biomass by other surveillance groups,
none could be directly used for the OIE global database on
antimicrobial agents intended for use in animals. Particularly,
these methodologies utilize available data on animal populations
detailed by production class, estimates of live animal weights,
import/export data, and total annual populations of production
groups living <1 year (i.e., poultry, veal calves, fattening pigs,
lambs, and kids). On a global level, such detailed data are
not yet available for many countries, and therefore a new
methodology was developed by the OIE mainly using globally
available datasets—the OIE World Animal Health Information
System (WAHIS) and the United Nations Food and Agriculture
Organization Statistics (FAOSTAT).
The formulas for calculating biomass by species were
developed using the two globally available datasets, WAHIS and
FAOSTAT, and were compared to references from countries
where more detailed animal population data by production class
were available. These references include animal biomass figures
either directly supplied from Member Countries, or calculated
from animal population data in Eurostat, the statistical office of
the European Union.
The formulas chosen for calculation of the OIE denominator
reflect the best fit estimations using the more general global
animal population data (WAHIS, FAOSTAT) when compared
to these available reference figures. The derived formulas were
then applied to all countries providing quantitative data for the
target year.
All weights and biomass figures are measured in
kilograms (kg).
Data collected by these global animal surveillance databases,
WAHIS and FAOSTAT, are point in time species-level census
data1 with little to no detail on the production class. Such data
are difficult to interpret given that production classes within a
species can have very different average weights, such as beef cattle
and veal calves. Additionally, given that census data are collected
at one point in time of the year, the total annual population
is not known for production groups which are slaughtered
and repopulated a certain number of times within 1 year (this
multiplication factor is hereafter referred to as “cycle factor”).
In development of the methodology for calculation of an
annual animal biomass, the underlying effort was to best use
globally available census data from the OIE WAHIS interface.
WAHIS data are reported by National Veterinary Services
through OIE Focal Points for Animal Disease Notification, and
the figures are subsequently validated by OIE staff.
FAOSTAT animal population data are used as a
complementary dataset. FAOSTAT data are similarly primarily
obtained from national governments, but sources expand beyond
National Veterinary Services to National Statistics Offices and
other relevant agencies. When a national government does not
report a figure to FAOSTAT, FAO uses local expert resources
to estimate a figure, or their statistical team to imputate a data
point. The two datasets are therefore similar but can display
significant variation.
Where census data were used, the WAHIS and FAOSTAT
figures are first cross-referenced with each other, and then with
national reports or literature as needed. FAOSTAT data are used
1Point in time census data represents the number of living animals in a country at
the time of survey.
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when a WAHIS data point is not available or is outside of
expected variation without explanation.
In addition to census data, FAOSTAT also reports numbers
and tons of production animal species slaughtered by country
each year, similarly undifferentiated by production class. As
WAHIS does not collect this information, FAOSTAT slaughter
data is used when these data were needed. For species
living <1 year, it was necessary to use data on number of
animals slaughtered to represent an annual population, as
this information cannot be extrapolated from point in time
census data without a cycle factor specific to each country’s
production model.
RESULTS
Principles of Animal Biomass Calculation
Methodology
The overall objective of the methodology is to obtain the biomass
of animals present during the year of analysis in a specific country
using internationally available data.
For a given species, animal weight varies by age and
production class, and therefore the structure of the population
of a given species must be taken into account.
The first approach is to distinguish animals from production
classes with a lifespan >1 year, and those with a lifespan of
<1 year.
For animals living for more than 1 year, it was considered
that census data (number of animals present at one time) can be
a good basis to evaluate the number of animals present in the
country during the year.
In this case, the biomass can be obtained by multiplying the
number of animals present at one point in time (census data)
by a calculated weight (if available or possible to calculate) or
standard weight.
Generally, census data available represent the number of
animals present at one point in time and include all animals
within the species regardless of their age and production class.
Thus, it is necessary to estimate the number of adults vs. young
animals to ensure appropriate average weights were applied.
Different methods for this estimation were used depending on
the species and available data.
For example, to differentiate breeding swine (sows) with
a production lifespan >1 year, from the fattening pigs, an
estimation of the percentage of sows in the total pig population
was calculated based on Eurostat data, where production-class
detailed information is available. To calculate the number of
sows, the percentage obtained was applied to the census data
as a constant for all the countries. For cattle, the approach
is different due to the large variation of body weight between
production classes (calves, young cattle, and adults), and a
broader diversity of production models (veal meat, beef meat,
milking cows, etc. . . ). For this species a model was built to
estimate the structure of an average bovine population, based
on Eurostat production-class information, and was applied to all
the countries.
The mean weight of adult animals was generally based on
existing standard weights, adapted regionally by livestock unit
classification (13). For animals living <1 year, production data
(number and weight of animals slaughtered annually) were
considered as a good basis to estimate the average weight of
animals present in the country during the year.
The application of these principles for calculating mean
weights depends on the species; in some species, like poultry,
mainly young animals are slaughtered (with a production life less
than a year). In other species like cattle, goats, sheep, and swine,
despite a large number of young animals being slaughtered,
adults (with a production life greater than a year) may represent
a significant portion of the population.
Calculation Methodology of Average
Animal Weights
Different antimicrobial use surveillance programmes have used
various methodologies for determining the average animal
weights used in the calculation of total biomass.
In the European Surveillance of Veterinary Antimicrobial
Consumption (ESVAC), estimated average weights at time of
treatment are used (9). The Canadian Integrated Surveillance
Program for Antimicrobial Resistance (CIPARS) also uses the
same estimated weights at time of treatment, as well as Canadian
standard weights (10). The surveillance programs of Japan and
the United States (12) take a different approach, instead using
more general estimates of average animal weights by production
category, rather than focusing the estimates on an average size
at treatment.
On a global scale, it was not considered feasible to estimate
weights at time of treatment for all countries reporting data to
the OIE. The live weight of the animal before slaughter was most
easily accessible, and was considered to be a best representation
of average weights for a global calculation of animal biomass.
The live weights of animals before slaughter were calculated
using FAOSTAT annual slaughter data, for all species and regions
where these data were available, using the following two formulas:
carcass weight (kg) =
total weight of species slaughtered (kg)
number of species slaughtered (heads)
Carcass weights were converted to live weights at time of
slaughter using conversion coefficients (k) as defined by Eurostat,
also known as dressing percentages (14). Conversion coefficients
represent the difference between a processed carcass weight and
the expected live weight of that animal species before slaughter,
expressed as a fraction.
live weight (kg) =
carcass weight (kg)
conversion coefficient (k)
Bovine (including cattle and domestic buffalo) biomass was
calculated according to the following principles:
1. Countries were grouped by sub-region as defined by livestock
unit classifications (13). A sub-regional mean live weight was
then determined by calculating the average live weight of
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bovines for countries within the sub-regional grouping from
their production data;
2. From the calculated sub-regional mean live weight, the
weights of the different bovine production categories [adults,
young (between 1 and 2 years of age), calves (<1 year of age)]
were determined by applying relevant weight proportions
standards, originating from livestock unit ratios defined by
Eurostat (15). Consecutively, the weight of each bovine
production category was then multiplied by a predicted
population ratio. These population ratios were calculated in
the reference Eurostat database and consider an anticipated
renewal rate of 30%.
Bovine biomass was calculated by multiplying the
representative weight determined for each sub-region by
the census population of bovines for each country within the
sub-region, according to the following formula:
census population× [
(
sub regional mean live weight
×LSUcalves × P.popcalves
)
+
(
sub regional mean live weight
×LSUyoung 1−2yrs × P.popyoung 1−2yrs
)
+
(
sub regional mean live weight × LSUadults × P.popadults
)
]
Whereby,
P.popcalves, P.popyoung 1−2years, P.popadults represents,
respectively, the proportion (P.pop) of calves, young (between 1
and 2 years of age) and adults in the total living cattle population,
as calculated from Eurostat animal population data.
LSUcalves, LSU young 1−2years, LSU adults represents, respectively,
the livestock unit ratios (LSU) for calves, young and adults as
defined by Eurostat (15).
And, sub regional mean live weight represents the calculated
mean live weight for adult cattle at the sub regional level.
Determination of the Mean Live Weight of Adult Cattle
The mean live weight of adult cattle is estimated by calculating a
Generic mean live weight at slaughter from the production data
which is then multiplied by a correction factor, derived from the
Eurostat reference dataset.
Mean weight of live adult cattle=Generic mean live weight at
slaughter ∗ Correction factor (1.15).
Generic Mean Live Weight at Slaughter
The Generic mean live weight at slaughter, comprised of the
weights of all the cattle slaughtered regardless of their production
category, is calculated from annual production data (FAOSTAT),
using the carcass to live weight conversion coefficient (÷ 0.54,
formula 4.2.2.2), as defined by Eurostat:
Generic mean live weight at slaughter (kg) =
Generic carcass weight (kg)
conversion coefficient (0.54)
Determination of the Correction Coefficient
Using reference datasets (Eurostat and several national detailed
reports), where slaughter data are detailed by production
category [adults, young (between 1 and 2 years of age), calves (<1
year of age)], it was estimated that, on average, the mean weight
of live adult cattle was 15% higher than the Generic mean live
weight at slaughter.
mean live weight of adults at time of slaughter
Generic mean live weight at slaughter
= 1.15
Therefore, applying an add-on factor of 15% (×1.15) to the
Generic mean live weight at slaughter is the best fit model to
obtain the mean live weight of adult cattle when compared to the
reference datasets (Eurostat and country specific data).
Sub-Regional Mean Live Weight
Countries were grouped by sub-region as defined by livestock
unit classifications (13). A sub-regional mean live weight
was then determined by calculating the average of the mean
live weight of adult cattle for countries within the sub-
regional grouping.
Swine biomass was calculated according to the
following formula:
(
live weight × number slaughtered
)
+ (census population
× sow weight × 0.09)
Whereby,
live weight × number slaughtered represents the expected
biomass of fattening pigs slaughtered in a country in 1 year,
And census population × sow weight × 0.09 represents
the expected biomass of pigs retained for breeding purposes,
calculated with the following considerations:
◦ The number of boars for breeding purposes is negligible
compared to the number of sows;
◦ Sow weight: the standard weight of a sow in Europe is 240 kg
(9). This weight was adapted by region using livestock unit
ratios (Americas = 240 kg, Asia and the Pacific = 240 kg,
Africa= 192 kg);
◦ 0.09 is the expected percentage of sows in a given
swine population, as calculated from Eurostat animal
population data.
Poultry biomass was calculated according to the
following formula:
(
live weight chicken × number of chicken slaughtered
)
+
(
live weight turkey × number of turkey slaughtered
)
+
(
live weight ducks × number of ducks slaughtered
)
+
(
live weight geese × number of geese slaughtered
)
Equidae biomass was calculated according to the
following formula:
(
live weight horse × horse census population
)
+
(
live weight donkey × donkey census population
)
+
(
live weight mules × mule census population
)
The live weight of horses, donkeys, and mules was calculated
for regions where equine slaughter is common and data were
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available. For regions where equine slaughter is not practiced
and/or where data were unavailable, live weights were adapted
using livestock unit ratios.
Sheep and goat biomass were calculated according to the
following formula:
(
live weight × number slaughtered
)
+
(
census population−
number slaughtered
1.5
)
× 75 kg
Whereby,(
live weight × number slaughtered
)
represents the expected
biomass of sheep and goats slaughtered in a country in 1 year,
And
(
census population−
number slaughtered
1.5
)
× 75 kg
represents the expected biomass of animals retained for breeding
purposes, calculated with the following considerations:
◦ 1.5 is the average number of breeding cycles per year;
◦ The standard weight of a breeding small ruminant in Europe
is 75 kg (9). This weight was used globally based on livestock
unit ratios.
Rabbit biomass was calculated according to the
following formula:
(
live weight × number slaughtered
)
+
(
census population−
number slaughtered
5
)
× 4.5 kg
Whereby,(
live weight × number slaughtered
)
represents the expected
biomass of rabbits slaughtered in a country in 1 year,
And
(
census population−
number slaughtered
5
)
× 4.5 kg
represents the expected biomass of animals retained for breeding
purposes, calculated with the following considerations:
◦ 5 is the average number of breeding cycles per year;
◦ The standard weight of a breeding doe is 4.5 kg.
Camelid and cervid biomass were calculated according to the
following formula:
standard weight × census population
According to the following considerations (16):
◦ Standard weight cervid: 80 kg
◦ Standard weight camel: 600 kg
◦ Standard weight, llama/alpaca: 100 kg
Farmed fish biomass was included in the total biomass only
for countries that included aquaculture in their reported data
on antimicrobials intended for use in animals. Aquaculture
data are collected in WAHIS and FAOSTAT as tons produced
annually, which were converted to kilograms for the animal
biomass calculation.
Data on farmed crustaceans, molluscs and amphibians were
excluded given the relatively small size of these populations, and
inconsistency in their reporting.
Cats and dogs have not yet been included in the calculation
of animal biomass due to inconsistency in reporting of their
populations, and lack of information on average weights. For
the countries where companion animal data was available, their
contribution to overall animal biomass was found to be relatively
minor (<1%). In the future, an analysis of companion animal
data will hopefully become feasible.
DISCUSSION
Limitations
The OIE data collection on antimicrobials intended for use in
animals is at an early stage of development and caution should
therefore be taken when interpreting the data of the first years of
data collection.
Multiple data sources are used by the different countries
including imports, wholesalers data, marketing authorization
holder declarations, and veterinary prescription. The level of
accuracy of the datamay be different according to the data source,
for example import data may be relatively imprecise compared to
marketing holder declarations or veterinary prescriptions.
In some cases, reporting of many different data sources can
also result in over-estimated, duplicated or overlapping data. The
OIE works with its Member Countries to correct thee issues
wherever possible.
The OIE will continue to support its Member Countries
through its Regional Trainings for National Focal Points for
Veterinary Products, where the guidelines are reviewed and
Member Countries can ask the OIE questions and share
experiences with their peers.
As stated in the annual European Surveillance of Veterinary
Antimicrobial Consumption (ESVAC) report, 3–4 years are
needed to establish a valid baseline for the data on sales of
veterinary antimicrobial agents.
The animal biomass methodology was developed taking
into account internationally available data. The level of detail
of information available on a global level necessitated the
development of a methodology partly based on informed
assumptions or extrapolations, which cannot accurately
represent the situation in every country. For example, the
methodology for calculating an average animal weight from
slaughter data, necessitates a conversion coefficient from carcass
weight to live weight at time of slaughter. Presently, the European
conversion coefficients were used for all the countries, but it is
not currently known how well these apply to other countries that
may have different slaughter practices, different breeds etc.
In the absence of global animal population data detailed
by age and production, extrapolations were also calculated
from European references. The extent to which these age
class distributions of species apply to other countries is still
undergoing a validation process.
The methodology for calculating biomass in several species
is based on the mean standard weight of animals for breeding.
An effort was undertaken to adapt these mean standard weights
between regions using livestock units (13). A review of how well
these standard weights depict the variability at a regional and
national level has been initiated.
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For cervids, camelids, and equines in some regions, data on
breeding cycles were not collected at the time of reporting, nor
was slaughter data. Therefore, this information was taken from
literature where necessary, or extrapolated from regions where
data was available (such as in the case of live weights of equines).
The extent to which these literature and extrapolated weights and
reproduction rates represent the true situation in any country is
expected to vary.
Imported and exported animals are commonly subtracted and
added, respectively, from animal populations when calculating
animal biomass, as done in ESVAC and CIPARS. This is done
so that only animals raised in the country, the time during which
they would have been treated with antimicrobials, are considered.
Currently, available data does not support incorporation of
imported and exported animals. Their contribution to overall
animal biomass was found to be relatively minor when calculated
for certain countries where data was available.
In development of the current denominator methodology, it
was decided at this time not to include companion animals in
the calculation of animal biomass. Data on populations of cats
and dogs are available in WAHIS, however, many countries do
not report these figures, or report them inconsistently. Another
consideration is the need to better understand whether reported
cat and dog populations represent owned or stray animals, as this
would affect the likelihood of their treatment with antimicrobials.
For the countries where cat and dog populations were
available, it was seen that their contribution to overall biomass
was minor (<1%). However, as some countries do include
antimicrobials used in companion animals in their reported
quantitative data, there is expected to be a small effect on results
by excluding these species. As excluding them decreases this
denominator, this effect, if any, would be a minor increase in
antimicrobial quantities adjusted for animal biomass.
In the future, a goal would be to provide a separate analysis
for antimicrobial agents used in companion animals, as more
countries are able to report these population data, and distinguish
antimicrobial quantities by animal group.
Prospects
The OIE will continue working closely with its Member
Countries to support them in calculating kilograms of active
ingredients of antimicrobials. An automated system for this
calculation (conversion of antimicrobial active ingredients in
veterinary medicines into kilograms) will be developed over time
to assist Member Countries in this effort. This automated system
will particularly help Member Countries with the burden of
manually calculating kilograms of active ingredients and avoid
errors with these calculations.
The OIE will also continue to refine its methodology for
the calculation of animal biomass, based on globally available
data, and communication with its Member Countries through its
regional offices.
An important next step in this process is collaboration
with the OIE World Animal Health Information and Analysis
Department (WAHIAD). In consultation with the OIE ad hoc
Group on Antimicrobial Resistance, new species and animal sub-
categories have been added to the OIE World Animal Health
Information System (WAHIS) data collection guidelines. These
new population sub-categories are now being implemented in
WAHIS and will allow to refine the data on animal biomass
over time.
OIE-WAHIS, the next generation of the WAHIS data
collection interface, is currently in development and will
incorporate further updates to the collection of global animal
population data. In addition to more sub-categories representing
detailed production data when Member Countries are able to
supply it, the interface will also include free text boxes allowing
for description of the reported data. OIE-WAHIS will also
additionally support the reporting of data on average live weights
and number of animals slaughtered in Member Countries.
Aside from collection of more detailed global animal
population data, more work is needed to validate some of
the conversion coefficients, breeding cycles and population
distribution ratios used in the methodology, which were
extrapolated from European data as necessary. Particularly,
better understanding potential regional variation in carcass
conversion coefficients (for estimating live weights) and annual
multiplication rates of species living <1 year (i.e., “cycle factor”)
are necessary within the current methodology to ensure its
applicability on a global scale. The OIE is currently working with
its Regional Offices to obtain better estimates on these variables
across regions.
The third AMU report published by the OIE in 2019 clearly
shows the significant commitment of OIE Member Countries
to the development of data collection systems on antimicrobial
agents intended for use in animals. The capacity to measure
trends over time is progressing each year, and is critical to the
international effort to promote the responsible and prudent use
of antimicrobial agents in animals.
Simultaneously, as more precise data on animal populations
becomes globally available, it is expected that the methodology
for calculation of animal biomass will be further refined. With
the concurrent development of quantitative data collection and
calculation of animal biomass, this annual report will allow for
increasingly effective comparisons on a global and regional scale.
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